{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:25:48Z","timestamp":1793139948733,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,20]],"date-time":"2024-10-20T00:00:00Z","timestamp":1729382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,20]],"date-time":"2024-10-20T00:00:00Z","timestamp":1729382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Health and Technology Project of Hangzhou","award":["A20210162"],"award-info":[{"award-number":["A20210162"]}]},{"name":"Zhejiang Medical Science and Technology Project","award":["2024KY230"],"award-info":[{"award-number":["2024KY230"]}]},{"name":"Zhejiang Medical Science and Technology Project","award":["2022507093"],"award-info":[{"award-number":["2022507093"]}]},{"name":"Hangzhou Health and Technology Project","award":["ZD20210043"],"award-info":[{"award-number":["ZD20210043"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-76355-4","type":"journal-article","created":{"date-parts":[[2024,10,20]],"date-time":"2024-10-20T17:01:37Z","timestamp":1729443697000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The mendelian randomized study revealed the association of prostatitis with prostate cancer risk"],"prefix":"10.1038","volume":"14","author":[{"given":"Jun","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huadong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,20]]},"reference":[{"issue":"1","key":"76355_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, 2023. CA Cancer J. Clin. 73 (1), 17\u201348. https:\/\/doi.org\/10.3322\/caac.21763 (2023).","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"76355_CR2","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.eururo.2021.12.039","volume":"81","author":"Q Cheng","year":"2022","unstructured":"Cheng, Q. et al. Pre-existing castration-resistant prostate cancer-like cells in primary prostate cancer promote resistance to hormonal therapy. Eur. Urol. 81 (5), 446\u2013455. https:\/\/doi.org\/10.1016\/j.eururo.2021.12.039 (2022).","journal-title":"Eur. Urol."},{"issue":"4","key":"76355_CR3","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s11255-019-02339-3","volume":"52","author":"H Kodama","year":"2020","unstructured":"Kodama, H. et al. Castration-resistant prostate cancer without metastasis at presentation may achieve cancer-specific survival in patients who underwent prior radical prostatectomy. Int. Urol. Nephrol. 52 (4), 671\u2013679. https:\/\/doi.org\/10.1007\/s11255-019-02339-3 (2020).","journal-title":"Int. Urol. Nephrol."},{"issue":"2","key":"76355_CR4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","volume":"84","author":"O Bergengren","year":"2023","unstructured":"Bergengren, O. et al. 2022 update on prostate cancer epidemiology and risk factors\u2014a systematic review. Eur. Urol. 84 (2), 191\u2013206. https:\/\/doi.org\/10.1016\/j.eururo.2023.04.021 (2023).","journal-title":"Eur. Urol."},{"issue":"Suppl 1","key":"76355_CR5","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1016\/j.ijantimicag.2007.08.028","volume":"31","author":"JN Krieger","year":"2008","unstructured":"Krieger, J. N. et al. Epidemiology of prostatitis. Int. J. Antimicrob. Agents. 31 (Suppl 1), S85\u201390. https:\/\/doi.org\/10.1016\/j.ijantimicag.2007.08.028 (2008).","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"12","key":"76355_CR6","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.3390\/cancers15123110","volume":"15","author":"SO Oseni","year":"2023","unstructured":"Oseni, S. O. et al. The molecular basis and clinical consequences of chronic inflammation in prostatic diseases: prostatitis, benign prostatic hyperplasia, and prostate cancer. Cancers (Basel). 15 (12), 3110. https:\/\/doi.org\/10.3390\/cancers15123110 (2023).","journal-title":"Cancers (Basel)"},{"issue":"5","key":"76355_CR7","doi-asserted-by":"publisher","first-page":"eabl5420","DOI":"10.1126\/sciadv.abl5420","volume":"8","author":"R De Matteis","year":"2022","unstructured":"De Matteis, R. et al. Aspirin activates resolution pathways to reprogram T cell and macrophage responses in colitis-associated colorectal cancer. Sci. Adv. 8 (5), eabl5420. https:\/\/doi.org\/10.1126\/sciadv.abl5420 (2022).","journal-title":"Sci. Adv."},{"issue":"2","key":"76355_CR8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3322\/caac.21263","volume":"65","author":"MK Barton","year":"2015","unstructured":"Barton, M. K. Daily aspirin may reduce mortality from prostate cancer with risk of high recurrence. CA Cancer J. Clin. 65 (2), 83\u201384. https:\/\/doi.org\/10.3322\/caac.21263 (2015).","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"76355_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/pcan.2015.54","volume":"19","author":"B Rybicki","year":"2016","unstructured":"Rybicki, B. et al. Racial differences in the relationship between clinical prostatitis, presence of inflammation in benign prostate and subsequent risk of prostate cancer. Prostate Cancer Prostatic Dis. 19 (2), 145\u2013150. https:\/\/doi.org\/10.1038\/pcan.2015.54 (2016).","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"7203","key":"76355_CR10","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani, A., Allavena, P., Sica, A. & Balkwill, F. Cancer-related inflammation. Nature. 454 (7203), 436\u2013444. https:\/\/doi.org\/10.1038\/nature07205 (2008).","journal-title":"Nature"},{"issue":"6917","key":"76355_CR11","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature. 420 (6917), 860\u2013867. https:\/\/doi.org\/10.1038\/nature01322 (2002).","journal-title":"Nature"},{"key":"76355_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-012418-012718","volume":"15","author":"M Locati","year":"2020","unstructured":"Locati, M., Curtale, G., Mantovani, A. & Diversity mechanisms and significance of macrophage plasticity. Annu. Rev. Pathol. 15, 123\u2013147. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-012418-012718 (2020).","journal-title":"Annu. Rev. Pathol."},{"issue":"1","key":"76355_CR13","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s40168-022-01289-w","volume":"10","author":"W Zhong","year":"2022","unstructured":"Zhong, W. et al. Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-\u03baB-IL6-STAT3 axis. Microbiome. 10 (1), 94. https:\/\/doi.org\/10.1186\/s40168-022-01289-w (2022).","journal-title":"Microbiome"},{"issue":"11","key":"76355_CR14","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrc3611","volume":"13","author":"E Elinav","year":"2013","unstructured":"Elinav, E. et al. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat. Rev. Cancer. 13 (11), 759\u2013771. https:\/\/doi.org\/10.1038\/nrc3611 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"76355_CR15","doi-asserted-by":"publisher","first-page":"107538","DOI":"10.1016\/j.pharmthera.2020.107538","volume":"211","author":"SE Thomas-Jardin","year":"2020","unstructured":"Thomas-Jardin, S. E., Dahl, H., Nawas, A. F., Bautista, M. & Delk, N. A. NF-\u03baB signaling promotes castration-resistant prostate cancer initiation and progression. Pharmacol. Ther. 211, 107538. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107538 (2020).","journal-title":"Pharmacol. Ther."},{"issue":"11","key":"76355_CR16","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1038\/s41588-021-00945-5","volume":"53","author":"E Mountjoy","year":"2021","unstructured":"Mountjoy, E. et al. An open approach to systematically prioritize causal variants and genes at all published human GWAS trait-associated loci. Nat. Genet. 53 (11), 1527\u20131533. https:\/\/doi.org\/10.1038\/s41588-021-00945-5 (2021).","journal-title":"Nat. Genet."},{"issue":"7944","key":"76355_CR17","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki, M. I. et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 613 (7944), 508\u2013518. https:\/\/doi.org\/10.1038\/s41586-022-05473-8 (2023).","journal-title":"Nature"},{"issue":"5","key":"76355_CR18","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1038\/mp.2016.252","volume":"23","author":"J Vaucher","year":"2018","unstructured":"Vaucher, J. et al. Cannabis use and risk of schizophrenia: a mendelian randomization study. Mol. Psychiatry. 23 (5), 1287\u20131292. https:\/\/doi.org\/10.1038\/mp.2016.252 (2018).","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"76355_CR19","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/ije\/dyq151","volume":"40","author":"BL Pierce","year":"2011","unstructured":"Pierce, B. L., Ahsan, H. & VanderWeele, T. J. Power and instrument strength requirements for mendelian randomization studies using multiple genetic variants. Int. J. Epidemiol. 40 (3), 740\u2013752. https:\/\/doi.org\/10.1093\/ije\/dyq151 (2011).","journal-title":"Int. J. Epidemiol."},{"issue":"2","key":"76355_CR20","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden, J., Davey Smith, G. & Burgess, S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int. J. Epidemiol. 44 (2), 512\u2013525. https:\/\/doi.org\/10.1093\/ije\/dyv080 (2015).","journal-title":"Int. J. Epidemiol."},{"issue":"3","key":"76355_CR21","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2307\/2171753","volume":"65","author":"D Staiger","year":"1997","unstructured":"Staiger, D. & Stock, J. H. Instrumental variables regression with weak instruments. Econometrica. 65 (3), 557\u2013586. https:\/\/doi.org\/10.2307\/2171753 (1997).","journal-title":"Econometrica"},{"issue":"7726","key":"76355_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 562 (7726), 203\u2013209. https:\/\/doi.org\/10.1038\/s41586-018-0579-z (2018).","journal-title":"Nature"},{"issue":"D1","key":"76355_CR23","doi-asserted-by":"publisher","first-page":"D11","DOI":"10.1093\/nar\/gkab1127","volume":"50","author":"G Cantelli","year":"2022","unstructured":"Cantelli, G. et al. The European Bioinformatics Institute (EMBL-EBI) in 2021. Nucleic Acids Res. 50 (D1), D11\u2013D19. https:\/\/doi.org\/10.1093\/nar\/gkab1127 (2022).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"76355_CR24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12916-023-02761-6","volume":"21","author":"Y Long","year":"2023","unstructured":"Long, Y., Tang, L., Zhou, Y., Zhao, S. & Zhu, H. Causal relationship between gut microbiota and cancers: a two-sample mendelian randomisation study. BMC Med. 21 (1), 66. https:\/\/doi.org\/10.1186\/s12916-023-02761-6 (2023).","journal-title":"BMC Med."},{"issue":"11","key":"76355_CR25","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1002\/sim.6835","volume":"35","author":"S Burgess","year":"2016","unstructured":"Burgess, S., Dudbridge, F. & Thompson, S. G. Combining information on multiple instrumental variables in mendelian randomization: comparison of allele score and summarized data methods. Stat. Med. 35 (11), 1880\u20131906. https:\/\/doi.org\/10.1002\/sim.6835 (2016).","journal-title":"Stat. Med."},{"issue":"4","key":"76355_CR26","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/jrsm.1346","volume":"10","author":"J Bowden","year":"2019","unstructured":"Bowden, J. & Holmes, M. V. Meta-analysis and mendelian randomization: a review. Res. Synth. Methods. 10 (4), 486\u2013496. https:\/\/doi.org\/10.1002\/jrsm.1346 (2019).","journal-title":"Res. Synth. Methods"},{"issue":"5","key":"76355_CR27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess, S. & Thompson, S. G. Interpreting findings from mendelian randomization using the MR-Egger method. Eur. J. Epidemiol. 32 (5), 377\u2013389. https:\/\/doi.org\/10.1007\/s10654-017-0255-x (2017).","journal-title":"Eur. J. Epidemiol."},{"issue":"7","key":"76355_CR28","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.3390\/nu13072317","volume":"13","author":"M Wang","year":"2021","unstructured":"Wang, M. et al. Coffee consumption and prostate cancer risk: results from National Health and Nutrition Examination Survey 1999\u20132010 and mendelian randomization analyses. Nutrients. 13 (7), 2317. https:\/\/doi.org\/10.3390\/nu13072317 (2021).","journal-title":"Nutrients"},{"issue":"11","key":"76355_CR29","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1681\/ASN.2016010098","volume":"27","author":"P Sekula","year":"2016","unstructured":"Sekula, P., Del Greco, M. F., Pattaro, C. & K\u00f6ttgen, A. Mendelian randomization as an approach to assess causality using observational data. J. Am. Soc. Nephrol. 27 (11), 3253\u20133265. https:\/\/doi.org\/10.1681\/ASN.2016010098 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"10","key":"76355_CR30","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/pros.22991","volume":"75","author":"D Dikov","year":"2015","unstructured":"Dikov, D., Bachurska, S., Staikov, D. & Sarafian, V. Intraepithelial lymphocytes in relation to NIH category IV prostatitis in autopsy prostate. Prostate. 75 (10), 1074\u20131084. https:\/\/doi.org\/10.1002\/pros.22991 (2015).","journal-title":"Prostate"},{"key":"76355_CR31","unstructured":"A Prospective Study of Chronic Inflammation in Benign Prostate Tissue and Risk of Prostate Cancer: Linked PCPT and SELECT Cohorts - PMC. Accessed December 18. (2023). https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5626618\/"},{"issue":"1","key":"76355_CR32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/s0891-5849(98)00042-2","volume":"25","author":"AG Fantel","year":"1998","unstructured":"Fantel, A. G., Mackler, B., Stamps, L. D., Tran, T. T. & Person, R. E. Reactive oxygen species and DNA oxidation in fetal rat tissues. Free Radic. Biol. Med. 25 (1), 95\u2013103. https:\/\/doi.org\/10.1016\/s0891-5849(98)00042-2 (1998).","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"76355_CR33","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1021\/acs.biomac.9b00054","volume":"20","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y. et al. Reactive oxygen species (ROS)-degradable polymeric nanoplatform for hypoxia-targeted gene delivery: unpacking DNA and reducing toxicity. Biomacromolecules. 20 (5), 1899\u20131913. https:\/\/doi.org\/10.1021\/acs.biomac.9b00054 (2019).","journal-title":"Biomacromolecules"},{"issue":"11","key":"76355_CR34","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.freeradbiomed.2010.09.006","volume":"49","author":"S Reuter","year":"2010","unstructured":"Reuter, S., Gupta, S. C., Chaturvedi, M. M. & Aggarwal, B. B. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic. Biol. Med. 49 (11), 1603\u20131616. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2010.09.006 (2010).","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"76355_CR35","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/j.1939-4640.2000.tb02135.x","volume":"21","author":"AR Shahed","year":"2000","unstructured":"Shahed, A. R. & Shoskes, D. A. Oxidative stress in prostatic fluid of patients with chronic pelvic pain syndrome: correlation with gram positive bacterial growth and treatment response. J. Androl. 21 (5), 669\u2013675 (2000).","journal-title":"J. Androl."},{"issue":"1","key":"76355_CR36","doi-asserted-by":"publisher","first-page":"e8736","DOI":"10.1371\/journal.pone.0008736","volume":"5","author":"I Cheng","year":"2010","unstructured":"Cheng, I. et al. Prostatitis, sexually transmitted diseases, and prostate cancer: the California men\u2019s Health Study. PLoS One. 5 (1), e8736. https:\/\/doi.org\/10.1371\/journal.pone.0008736 (2010).","journal-title":"PLoS One"},{"issue":"1","key":"76355_CR37","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/01.ede.0000101022.38330.7c","volume":"15","author":"RO Roberts","year":"2004","unstructured":"Roberts, R. O., Bergstralh, E. J., Bass, S. E., Lieber, M. M. & Jacobsen, S. J. Prostatitis as a risk factor for prostate cancer. Epidemiology. 15 (1), 93\u201399. https:\/\/doi.org\/10.1097\/01.ede.0000101022.38330.7c (2004).","journal-title":"Epidemiology"},{"issue":"4","key":"76355_CR38","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1056\/NEJMra021562","volume":"349","author":"WG Nelson","year":"2003","unstructured":"Nelson, W. G., De Marzo, A. M. & Isaacs, W. B. Prostate cancer. N Engl. J. Med. 349 (4), 366\u2013381. https:\/\/doi.org\/10.1056\/NEJMra021562 (2003).","journal-title":"N Engl. J. Med."},{"issue":"5","key":"76355_CR39","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/s0090-4295(00)00776-7","volume":"56","author":"MJ Putzi","year":"2000","unstructured":"Putzi, M. J. & De Marzo, A. M. Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia. Urology. 56 (5), 828\u2013832. https:\/\/doi.org\/10.1016\/s0090-4295(00)00776-7 (2000).","journal-title":"Urology"},{"issue":"9","key":"76355_CR40","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3390\/cells7090122","volume":"7","author":"J Staal","year":"2018","unstructured":"Staal, J. & Beyaert, R. Inflammation and NF-\u03baB signaling in prostate cancer: mechanisms and clinical implications. Cells. 7 (9), 122. https:\/\/doi.org\/10.3390\/cells7090122 (2018).","journal-title":"Cells"},{"issue":"23","key":"76355_CR41","doi-asserted-by":"publisher","first-page":"9181","DOI":"10.3390\/ijms21239181","volume":"21","author":"P Poma","year":"2020","unstructured":"Poma, P. NF-\u03baB and disease. Int. J. Mol. Sci. 21 (23), 9181. https:\/\/doi.org\/10.3390\/ijms21239181 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"76355_CR42","doi-asserted-by":"publisher","first-page":"6464","DOI":"10.3390\/ijms21186464","volume":"21","author":"Q Lyu","year":"2020","unstructured":"Lyu, Q. et al. Hsp70 and NF-kB mediated control of innate inflammatory responses in a canine macrophage cell line. Int. J. Mol. Sci. 21 (18), 6464. https:\/\/doi.org\/10.3390\/ijms21186464 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"76355_CR43","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.3390\/cancers12071887","volume":"12","author":"F Bonollo","year":"2020","unstructured":"Bonollo, F., Thalmann, G. N., Kruithof-de Julio, M. & Karkampouna, S. The role of cancer-associated fibroblasts in prostate cancer tumorigenesis. Cancers (Basel). 12 (7), 1887. https:\/\/doi.org\/10.3390\/cancers12071887 (2020).","journal-title":"Cancers (Basel)"},{"issue":"2","key":"76355_CR44","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1053\/j.seminoncol.2014.03.004","volume":"41","author":"P Chiarugi","year":"2014","unstructured":"Chiarugi, P., Paoli, P. & Cirri, P. Tumor microenvironment and metabolism in prostate cancer. Semin Oncol. 41 (2), 267\u2013280. https:\/\/doi.org\/10.1053\/j.seminoncol.2014.03.004 (2014).","journal-title":"Semin Oncol."},{"issue":"4","key":"76355_CR45","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/path.1427","volume":"200","author":"G Gabbiani","year":"2003","unstructured":"Gabbiani, G. The myofibroblast in wound healing and fibrocontractive diseases. J. Pathol. 200 (4), 500\u2013503. https:\/\/doi.org\/10.1002\/path.1427 (2003).","journal-title":"J. Pathol."},{"issue":"8","key":"76355_CR46","doi-asserted-by":"publisher","first-page":"a030510","DOI":"10.1101\/cshperspect.a030510","volume":"8","author":"C Levesque","year":"2018","unstructured":"Levesque, C. & Nelson, P. S. Cellular constituents of the prostate stroma: key contributors to prostate cancer progression and therapy resistance. Cold Spring Harb Perspect. Med. 8 (8), a030510. https:\/\/doi.org\/10.1101\/cshperspect.a030510 (2018).","journal-title":"Cold Spring Harb Perspect. Med."},{"issue":"3","key":"76355_CR47","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/1878-0261.13329","volume":"17","author":"L Schneider","year":"2023","unstructured":"Schneider, L. et al. Post-prostatic-massage urine exosomes of men with chronic prostatitis\/chronic pelvic pain syndrome carry prostate-cancer-typical microRNAs and activate proto-oncogenes. Mol. Oncol. 17 (3), 445\u2013468. https:\/\/doi.org\/10.1002\/1878-0261.13329 (2023).","journal-title":"Mol. Oncol."},{"issue":"5","key":"76355_CR48","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.juro.2017.11.120","volume":"199","author":"SR Vasavada","year":"2018","unstructured":"Vasavada, S. R., Dobbs, R. W., Kajdacsy -Balla Andr\u00e9, A., Abern, M. R. & Moreira, D. M. Inflammation on prostate needle biopsy is associated with lower prostate cancer risk: a meta-analysis. J. Urol. 199 (5), 1174\u20131181. https:\/\/doi.org\/10.1016\/j.juro.2017.11.120 (2018).","journal-title":"J. Urol."},{"issue":"2","key":"76355_CR49","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/cncr.28349","volume":"120","author":"DM Moreira","year":"2014","unstructured":"Moreira, D. M. et al. Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: results from the REDUCE study. Cancer. 120 (2), 190\u2013196. https:\/\/doi.org\/10.1002\/cncr.28349 (2014).","journal-title":"Cancer"},{"issue":"4","key":"76355_CR50","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/pcan.2017.30","volume":"20","author":"DM Moreira","year":"2017","unstructured":"Moreira, D. M. et al. The combination of histological prostate atrophy and inflammation is associated with lower risk of prostate cancer in biopsy specimens. Prostate Cancer Prostatic Dis. 20 (4), 413\u2013417. https:\/\/doi.org\/10.1038\/pcan.2017.30 (2017).","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"4","key":"76355_CR51","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1158\/1078-0432.CCR-16-0133","volume":"23","author":"DF Quail","year":"2017","unstructured":"Quail, D. F. & Joyce, J. A. Molecular pathways: deciphering mechanisms of resistance to macrophage-targeted therapies. Clin. Cancer Res. 23 (4), 876\u2013884. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-0133 (2017).","journal-title":"Clin. Cancer Res."},{"issue":"23","key":"76355_CR52","doi-asserted-by":"publisher","first-page":"11432","DOI":"10.1158\/0008-5472.CAN-06-1867","volume":"66","author":"A Saccani","year":"2006","unstructured":"Saccani, A. et al. p50 nuclear factor-kappab overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Res. 66 (23), 11432\u201311440. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-1867 (2006).","journal-title":"Cancer Res."},{"issue":"6","key":"76355_CR53","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1084\/jem.20080108","volume":"205","author":"T Hagemann","year":"2008","unstructured":"Hagemann, T. et al. Re-educating tumor-associated macrophages by targeting NF-kappaB. J. Exp. Med. 205 (6), 1261\u20131268. https:\/\/doi.org\/10.1084\/jem.20080108 (2008).","journal-title":"J. Exp. Med."},{"issue":"6923","key":"76355_CR54","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nature01283","volume":"421","author":"M Dajee","year":"2003","unstructured":"Dajee, M. et al. NF-kappaB blockade and oncogenic ras trigger invasive human epidermal neoplasia. Nature. 421 (6923), 639\u2013643. https:\/\/doi.org\/10.1038\/nature01283 (2003).","journal-title":"Nature"},{"issue":"5","key":"76355_CR55","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10654-021-00757-1","volume":"36","author":"AR Carter","year":"2021","unstructured":"Carter, A. R. et al. Mendelian randomisation for mediation analysis: current methods and challenges for implementation. Eur. J. Epidemiol. 36 (5), 465\u2013478. https:\/\/doi.org\/10.1007\/s10654-021-00757-1 (2021).","journal-title":"Eur. J. Epidemiol."},{"issue":"1","key":"76355_CR56","first-page":"3","volume":"1","author":"KS Sfanos","year":"2013","unstructured":"Sfanos, K. S., Isaacs, W. B. & Marzo, A. M. D. Infections and inflammation in prostate cancer. Am. J. Clin. Exp. Urol. 1 (1), 3\u201311 (2013).","journal-title":"Am. J. Clin. Exp. Urol."},{"issue":"1","key":"76355_CR57","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrurol.2017.167","volume":"15","author":"KS Sfanos","year":"2018","unstructured":"Sfanos, K. S., Yegnasubramanian, S., Nelson, W. G. & De Marzo, A. M. The inflammatory microenvironment and microbiome in prostate cancer development. Nat. Rev. Urol. 15 (1), 11\u201324. https:\/\/doi.org\/10.1038\/nrurol.2017.167 (2018).","journal-title":"Nat. Rev. Urol."},{"issue":"2","key":"76355_CR58","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","volume":"63","author":"M Burger","year":"2013","unstructured":"Burger, M. et al. Epidemiology and risk factors of urothelial bladder cancer. Eur. Urol. 63 (2), 234\u2013241. https:\/\/doi.org\/10.1016\/j.eururo.2012.07.033 (2013).","journal-title":"Eur. Urol."},{"issue":"1","key":"76355_CR59","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","volume":"30","author":"I Vitale","year":"2019","unstructured":"Vitale, I., Manic, G., Coussens, L. M., Kroemer, G. & Galluzzi, L. Macrophages and metabolism in the tumor microenvironment. Cell. Metab. 30 (1), 36\u201350. https:\/\/doi.org\/10.1016\/j.cmet.2019.06.001 (2019).","journal-title":"Cell. Metab."},{"issue":"1","key":"76355_CR60","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12916-021-02193-0","volume":"20","author":"E Bouras","year":"2022","unstructured":"Bouras, E. et al. Circulating inflammatory cytokines and risk of five cancers: a mendelian randomization analysis. BMC Med. 20 (1), 3. https:\/\/doi.org\/10.1186\/s12916-021-02193-0 (2022).","journal-title":"BMC Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76355-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76355-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76355-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T05:18:05Z","timestamp":1729747085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76355-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,20]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["76355"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-76355-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,20]]},"assertion":[{"value":"2 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This research has been approved by the Ethics Committee of Hangzhou First People\u2019s Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"24643"}}